Figures & data
Figure 1 Ribbon representation of HIV-1 RT-GSK952 complex.
Abbreviations: RT, reverse transcriptase; PDB, Protein Data Base.
![Figure 1 Ribbon representation of HIV-1 RT-GSK952 complex.](/cms/asset/9ffe174c-6063-46db-9870-8046b56f4465/dddt_a_12182245_f0001_c.jpg)
Figure 2 The 2D structure of ligand GSK952 used to generate the pharmacophore model.
![Figure 2 The 2D structure of ligand GSK952 used to generate the pharmacophore model.](/cms/asset/6d4cc7aa-8798-4dc1-9d18-3e738199405a/dddt_a_12182245_f0002_c.jpg)
Figure 3 A schematic representation of the VS workflow used in the current study.
![Figure 3 A schematic representation of the VS workflow used in the current study.](/cms/asset/c787225f-b0c6-4c14-a65c-34fc47c96fc0/dddt_a_12182245_f0003_b.jpg)
Figure 4 A diagrammatic representation of the pharmacophore model.
Abbreviations: PRED, per-residue energy decomposition; FBE, free binding energy; vdW, van der Waals; Elec, electrostatic; 2D, two dimensional.
![Figure 4 A diagrammatic representation of the pharmacophore model.](/cms/asset/495adb03-0c75-42bf-9149-fad932f16f96/dddt_a_12182245_f0004_c.jpg)
Table 1 Validation of molecular docking approach
Figure 5 Validation of molecular docking: docking score vs half maximal inhibitory concentration (IC50).
![Figure 5 Validation of molecular docking: docking score vs half maximal inhibitory concentration (IC50).](/cms/asset/847bc463-24ca-4512-8573-cc2a7e1b2f47/dddt_a_12182245_f0005_b.jpg)
Table 2 Representation of the top ten compounds displaying 3D shapes, HBD, HBA, xlogP, MW, and calculated DS and RB
Table 3 A comparison of GSK952’s binding affinity with that of the top two hits ZINC54359621 and ZINC46849657
Figure 6 The per residue graphs showing FBE contribution for both ZINC54359621 and ZINC46849657.
Abbreviations: FBE, free binding energy; vdW, van der Waals; Elec, electrostatic.
![Figure 6 The per residue graphs showing FBE contribution for both ZINC54359621 and ZINC46849657.](/cms/asset/033f81af-9b1f-428d-9d4b-190649690d9a/dddt_a_12182245_f0006_c.jpg)
Figure 7 Binding mode of compounds.
Abbreviation: RT, reverse transcriptase.
![Figure 7 Binding mode of compounds.](/cms/asset/8da30644-531c-49f4-a981-137d4c648d7a/dddt_a_12182245_f0007_c.jpg)
Figure S1 Two key binding interactions exist between GSK952 and the backbone NH and C=O groups of Lys103 of HIV-1 RT.
![Figure S1 Two key binding interactions exist between GSK952 and the backbone NH and C=O groups of Lys103 of HIV-1 RT.](/cms/asset/cd764db4-8ff6-423e-ad85-97bed43a3088/dddt_a_12182245_s0001_c.gif)
Figure S2 PRED-based pharmacophore model.
![Figure S2 PRED-based pharmacophore model.](/cms/asset/6123f20b-9797-4e6d-8c03-b3bb79bcf466/dddt_a_12182245_s0002_c.gif)
Figure S3 MD simulation results of ZINC54359621 and ZINC46849657.
Abbreviations: MD, molecular dynamic; RMSD, root-mean-square deviation; RMSF, root-mean-square fluctuation; Rg, radius of gyration.
![Figure S3 MD simulation results of ZINC54359621 and ZINC46849657.](/cms/asset/d3726896-e315-45e1-9438-413e486c4ff5/dddt_a_12182245_s0003_c.gif)
Table S1 PRED of highly interacting residues